Medication Fact Sheets
|
January 8, 2025

What Is Fluticasone Furoate? Your Complete Guide

Written By
Medically Reviewed by
Dr. Ayesha Bryant MSPH, MD
Updated On
January 15, 2025

Managing nasal or respiratory conditions can be challenging, but fluticasone furoate may help patients effectively manage symptoms. This commonly prescribed corticosteroid targets inflammation in the airways, providing relief from symptoms like congestion and difficulty breathing. 

It is widely used to manage seasonal allergies, asthma, and other chronic respiratory concerns. In this article, we’ll explore fluticasone furoate's essential details, including its primary uses, benefits, and potential side effects. 

[signup]

Understanding Fluticasone Furoate

Fluticasone furoate is a synthetic corticosteroid often prescribed for managing inflammatory and allergic conditions. Clinical studies have shown that it is designed to target glucocorticoid receptors and deliver localized effects with minimal systemic absorption. 

Its unique chemical structure allows for prolonged action, which can be convenient for some patients. This reduces the need for frequent dosing, enhancing convenience and compliance for patients. Additionally, its targeted delivery minimizes systemic exposure, reducing the risk of unwanted side effects.

Compared to corticosteroids such as budesonide or mometasone furoate, Fluticasone furoate stands out due to its enhanced affinity for glucocorticoid receptors and lower bioavailability. It delivers effective results at lower doses with minimal systemic side effects, offering a safer profile for long-term use.

How Does It Work?

Fluticasone furoate modulates the body’s inflammatory and immune responses. As a glucocorticoid receptor agonist, it is believed to help reduce the production of inflammatory mediators like histamines, cytokines, and prostaglandins. This action reduces swelling, irritation, and mucus production in affected tissues, relieving allergy and asthma symptoms.

The medication’s long duration of action is attributed to its high receptor-binding affinity and slow metabolic breakdown, making it a commonly prescribed option for once-daily dosing regimens. Clinical studies suggest it may provide symptom relief within 24 hours for some patients.

Applications and Uses

Fluticasone furoate is a commonly used medication to treat various inflammatory and allergic conditions. Some of the most common conditions it addresses include:

  • Chronic Rhinosinusitis: Relieves nasal inflammation, alleviating congestion, and improving sinus drainage.
  • Allergic Rhinitis: Effectively controls symptoms such as sneezing, itching, and a runny or stuffy nose caused by seasonal or perennial allergies.
  • Asthma: Used as a maintenance therapy to reduce airway inflammation, prevent exacerbations, and improve overall lung function.
  • Chronic Obstructive Pulmonary Disease (COPD): Helps manage symptoms by reducing airway inflammation and improving breathing capacity.

The form of fluticasone furoate prescribed depends on the condition being treated. Nasal sprays are commonly used for rhinosinusitis and allergic rhinitis, offering localized relief in the nasal passages. For asthma and COPD, inhalers deliver the medication directly to the lungs for targeted action.

Fluticasone Furoate is often used as part of a broader treatment plan tailored to individual needs.

Dosage Forms and Administration

Fluticasone Furoate is available in various dosage forms to suit different medical needs, including:

  • Nasal Sprays: Designed for intranasal use, these sprays provide localized relief for nasal conditions.
  • Inhalers: Available in dry powder or metered-dose formats, inhalers deliver the medication directly to the lungs for respiratory conditions.
  • Combination Therapies: Often combined with long-acting beta-agonists (LABAs) for enhanced asthma and COPD management efficacy.

To maximize effectiveness, patients should follow proper usage guidelines:

  • Nasal Sprays: Clear nasal passages before use, tilt the head slightly forward, and aim the spray away from the nasal septum.
  • Inhalers: Exhale fully before inhaling the medication, hold your breath for a few seconds after use, and rinse the mouth afterward to prevent oral thrush.

Adherence to prescribed dosing schedules and techniques is key to achieving optimal therapeutic outcomes.

Benefits and Effectiveness

Clinical research supports fluticasone furoate's significant benefits in managing allergies and asthma. Studies highlight its effectiveness in reducing symptoms like nasal congestion, sneezing, and wheezing while improving overall respiratory function. 

For long-term management, fluticasone furoate excels in controlling chronic respiratory conditions like asthma and COPD. Regular use has been shown to decrease the frequency of exacerbations and hospital visits. Its ability to provide consistent symptom relief while minimizing systemic side effects makes it a reliable choice for ongoing care.

Risks and Side Effects

Like any medication, fluticasone furoate can cause side effects, although most are commonly reported as mild and self-resolving. Common side effects include dryness or irritation of the nasal passages, headaches, and occasional minor nosebleeds. These symptoms are typically manageable and often resolve as the body adjusts to the medication.

Patients using inhalers may experience mild side effects such as sore throat or hoarseness. To minimize these effects, users should follow proper administration techniques, such as rinsing the mouth after inhaler use. These practices can significantly reduce the likelihood of discomfort.

While these symptoms are generally manageable, following administration guidelines and consulting a healthcare provider regarding persistent or severe side effects is essential.

Serious Risks and Contraindications

Although rare, fluticasone furoate may lead to more serious side effects, such as adrenal suppression or weakened immune function, particularly with prolonged use or high doses. These risks emphasize the importance of adhering to prescribed dosages and consulting a healthcare provider for long-term use.

Individuals with specific conditions or allergies should exercise caution. For example, those with a known hypersensitivity to corticosteroids or a history of severe nasal infections should avoid this medication. 

A healthcare provider should evaluate any pre-existing medical conditions before initiating treatment to ensure safety.

Usage Guidelines and Precautions

Fluticasone furoate dosage varies based on age, condition, and the medication's form. 

  • For pediatric patients, nasal sprays are typically recommended in lower doses, with a single spray per nostril once daily being sufficient for children aged 2 to 11. In asthma management, inhalers may be prescribed in age-appropriate doses, ensuring safety and efficacy.
  • For adults and adolescents, the standard dosage for nasal sprays is two sprays per nostril once daily, which can be reduced to one spray per nostril for maintenance. Inhaler dosages are adjusted based on asthma or COPD severity, often ranging from low to medium doses for regular control. 
  • Elderly patients may require dose adjustments to account for age-related changes in drug metabolism, with close monitoring to ensure optimal results.  Older adults may be more susceptible to complications such as osteoporosis or infections.

Combining Fluticasone Furoate with Other Treatments

Fluticasone furoate can be combined with other treatments but may increase the risks of side effects.  Patients are advised to consult their healthcare provider to evaluate the safety and appropriateness of combining treatments. 

When used with long-acting beta-agonists (LABAs) in combination with inhalers, it enhances symptom control for asthma and COPD. However, combining it with other corticosteroids can increase the risk of side effects, such as adrenal suppression.

Patients should also avoid overuse or overlapping medications that provide similar effects. For example, using multiple corticosteroid formulations simultaneously may lead to an increased risk of systemic side effects. 

Always inform your healthcare provider of all medications and supplements being used to ensure a safe and effective treatment plan. Proper adherence to prescribed doses and regular follow-ups can help mitigate risks while maximizing benefits.

Availability and Cost

The availability of fluticasone furoate varies by region. Some countries offer it as an over-the-counter (OTC) medication for conditions like allergic rhinitis. In other areas, it is available by prescription only, especially for higher doses or formulations intended for asthma or COPD management

OTC options for nasal sprays treating mild allergies provide convenient access for patients. However, inhaler forms and combination therapies generally require a prescription to ensure proper diagnosis and dosage adjustments by a healthcare provider. Understanding regional differences can help patients navigate accessibility challenges effectively.

Patients considering OTC options should consult a pharmacist or healthcare provider to ensure appropriate use.

Insurance Coverage and Cost Considerations

The cost of fluticasone furoate varies significantly depending on the formulation, brand, and location. Brand-name versions are more expensive, but many generic alternatives offer the same efficacy at a lower cost. 

Insurance plans often cover fluticasone furoate, especially for asthma and COPD. Patients are advised to check with their providers for coverage details, as copayments and reimbursement policies may differ. 

For those without insurance, pharmacy discount programs or bulk purchasing options may help reduce expenses, ensuring cost-effectiveness without compromising care. Some manufacturers and nonprofit organizations also offer patient assistance programs to provide affordable access to essential medications.

[signup]

Key Takeaways

  • Fluticasone furoate is a potent corticosteroid that effectively reduces inflammation and improves breathing. It is a trusted treatment for allergies, asthma, and chronic respiratory conditions.
  • Its targeted action, high receptor-binding affinity, and low systemic absorption enable effective symptom relief with minimal side effects, often requiring only once-daily dosing for convenience and compliance.
  • It is available in nasal sprays for localized relief (e.g., allergic rhinitis and rhinosinusitis) and inhalers for respiratory conditions (e.g., asthma and COPD), with proper administration techniques crucial to maximizing its benefits.
  • Common side effects include nasal irritation, headaches, and sore throat. At the same time, rare risks like adrenal suppression highlight the importance of adhering to prescribed doses and consulting healthcare providers for long-term use.
  • Fluticasone furoate is available in various formulations, with costs varying by region, insurance coverage, and brand. Generic and assistance programs can improve affordability for patients.
The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.

Learn more

No items found.

Lab Tests in This Article

No lab tests!

Ahmet, A., Mokashi, A., Goldbloom, E.B., Huot, C., Jurencak, R., Krishnamoorthy, P., Rowan-Legg, A., Kim, H., Pancer, L. and Kovesi, T. (2019). Adrenal suppression from glucocorticoids: preventing an iatrogenic cause of morbidity and mortality in children. BMJ Paediatrics Open, [online] 3(1), p.e000569. doi:https://doi.org/10.1136/bmjpo-2019-000569.

Akhouri, S. and House, S.A. (2023). Allergic rhinitis. [online] PubMed. Available at: https://www.ncbi.nlm.nih.gov/books/NBK538186/.

Albertson, T.E., Richards, J.R. and Zeki, A.A. (2016). The combination of fluticasone furoate and vilanterol trifenatate in the management of asthma: clinical trial evidence and experience. Therapeutic Advances in Respiratory Disease, [online] 10(1), pp.43–56. doi:https://doi.org/10.1177/1753465815619136.

Alexandraki, K.I., Kaltsas, G.A. and Chrousos, G.P. (2018). Adrenal Suppression. [online] www.ncbi.nlm.nih.gov. Available at: https://www.ncbi.nlm.nih.gov/sites/books/NBK279047/.

Anolik, R. (2010). Fluticasone furoate nasal spray: Profile of an enhanced-affinity corticosteroid in treatment of seasonal allergic rhinitis. Journal of Asthma and Allergy, p.87. doi:https://doi.org/10.2147/jaa.s10839.

Chauhan, P., Nair, A., Patidar, A., Dandapat, J., Sarkar, A. and Saha, B. (2021). A primer on cytokines. Cytokine, 145, p.155458. doi:https://doi.org/10.1016/j.cyto.2021.155458.

Cloyd, J. (2023). A Functional Medicine Asthma Protocol: Testing, Nutritional Considerations, and Supplements. [online] Rupa Health. Available at: https://www.rupahealth.com/post/a-functional-medicine-asthma-protocol.

Cole, T.J., Short, K.L. and Hooper, S.B. (2019). The science of steroids. Seminars in Fetal & Neonatal Medicine, [online] 24(3), pp.170–175. doi:https://doi.org/10.1016/j.siny.2019.05.005.

Dougherty, J.M., Alsayouri, K. and Sadowski, A. (2020). Allergy. [online] PubMed. Available at: https://www.ncbi.nlm.nih.gov/books/NBK545237/.

Fluticasone Propionate. (2024). GoodRx. GoodRx. https://www.goodrx.com/fluticasone-propionate/medicare-coverage

Giavina-Bianchi, P. (2008). Fluticasone furoate nasal spray in the treatment of allergic rhinitis. Therapeutics and Clinical Risk Management, Volume 4, pp.465–472. doi:https://doi.org/10.2147/tcrm.s1984.

Hashmi, M.F. and Cataletto, M.E. (2024). Asthma. [online] PubMed. Available at: https://www.ncbi.nlm.nih.gov/books/NBK430901/.

Hodgens, A. and Sharman, T. (2022). Corticosteroids. [online] PubMed. Available at: https://pubmed.ncbi.nlm.nih.gov/32119499/.

Horak, F. (2008). Effectiveness of twice daily azelastine nasal spray in patients with seasonal allergic rhinitis. Therapeutics and Clinical Risk Management, Volume 4, pp.1009–1022. doi:https://doi.org/10.2147/tcrm.s3229.

Hsu, E. and Bajaj, T. (2023). Beta 2 Agonists. [online] National Library of Medicine. Available at: https://www.ncbi.nlm.nih.gov/books/NBK542249/.

Institute for Quality and Efficiency in Health Care (2022). Chronic obstructive pulmonary disease (COPD): Overview. [online] Nih.gov. Available at: https://www.ncbi.nlm.nih.gov/books/NBK315789/.

J.F. Maspero, A. Rosenblut, Finn, A., Lim, J., Wu, W., Faris, M. and Philpot, E. (2007). Once-daily Fluticasone Furoate∗ Nasal Spray (FF) is Safe and Effective in The Long-term Treatment of Perennial Allergic Rhinitis (PAR) in Children Ages 2 to 11 Years ∗USAN approved name. Journal of Allergy and Clinical Immunology, [online] 119(1), pp.S304–S304. doi:https://doi.org/10.1016/j.jaci.2006.12.562.

Justiz Vaillant, A.A., Sabir, S. and Jan, A. (2021). Physiology, Immune Response. [online] PubMed. Available at: https://pubmed.ncbi.nlm.nih.gov/30969623/.

Kaiser, F.E. and Doe, R.P. (1984). Steroid use in the elderly. Postgraduate Medicine, 76(1), pp.65–74. doi:https://doi.org/10.1080/00325481.1984.11698664.

Kalola, U.K. and Ambati, S. (2020). Budesonide. [online] PubMed. Available at: https://www.ncbi.nlm.nih.gov/books/NBK563201/.

Keating, M.K., Phillips, J.C. and Phillips, J. (2023). Chronic Rhinosinusitis. American Family Physician, [online] 108(4), pp.370–377. Available at: https://pubmed.ncbi.nlm.nih.gov/37843944/.

Khakham, C. (2023). Integrative medicine approach to asthma: Testing, dietary interventions, and natural remedies. [online] Rupa Health. Available at: https://www.rupahealth.com/post/integrative-medicine-approach-to-asthma-testing-dietary-interventions-and-natural-remedies.

Khan, K.S., Jawaid, S., Memon, U.A., Perera, T., Khan, U., Farwa, U.E., Jindal, U., Afzal, M.S., Razzaq, W., Abdin, Z.U. and Khawaja, U.A. (2023). Management of Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in Hospitalized Patients From Admission to Discharge: A Comprehensive Review of Therapeutic Interventions. Cureus, [online] 15(8). doi:https://doi.org/10.7759/cureus.43694.

Kumar, A., Jain, M.K., Barge, V.B., Kumar, R.S., Gupta, N., Yadav, H., Pal, A., Redkar, V.E., Mondal, A., Rathore, R.K., Daultani, P., Jaiswal, A. and Mehta, R.T. (2024). Efficacy and safety of Once-Daily Vilanterol/Fluticasone furoate MDI in persistent asthma: Phase 3 OD-INHALE Study. The Journal of asthma : official journal of the Association for the Care of Asthma, [online] 61(10), pp.1181–1189. doi:https://doi.org/10.1080/02770903.2024.2330485.

Malik, K. and Dua, A. (2022). Prostaglandins. [online] Nih.gov. Available at: https://www.ncbi.nlm.nih.gov/sites/books/NBK553155/ [Accessed 25 Nov. 2024].

Neibling, K. (2023a). Complementary and Integrative Treatments For Chronic Obstructive Pulmonary Disease (COPD). [online] Rupa Health. Available at: https://www.rupahealth.com/post/complementary-and-integrative-treatments-for-chronic-obstructive-pulmonary-disease-copd.

Neibling, K. (2023b). Integrative medicine treatment for headaches. [online] Rupa Health. Available at: https://www.rupahealth.com/post/integrative-medicine-treatment-for-headaches.

Oliver, A., Bjermer, L., Quinn, D., Saggu, P., Thomas, P., Yarnall, K. and Lötvall, J. (2013). Modulation of allergen‐induced bronchoconstriction by fluticasone furoate and vilanterol alone or in combination. Allergy, 68(9), pp.1136–1142. doi:https://doi.org/10.1111/all.12205.

Oronsky, B., Caroen, S. and Reid, T. (2022). What Exactly Is Inflammation (and What Is It Not?). International Journal of Molecular Sciences, [online] 23(23), p.14905. doi:https://doi.org/10.3390/ijms232314905.

Passali, D., Spinosi, M.C., Crisanti, A. and Bellussi, L.M. (2016). Mometasone furoate nasal spray: a systematic review. Multidisciplinary Respiratory Medicine, 11(1). doi:https://doi.org/10.1186/s40248-016-0054-3.

Patel, R.H. and Mohiuddin, S.S. (2023). Biochemistry, Histamine. [online] PubMed. Available at: https://www.ncbi.nlm.nih.gov/books/NBK557790/.

Prabhudesai, P., Singh, B.P., Agrawal, G., Singh, A.K., Jadhav, A.Y., Patil, S.R., Bhagat, S., Patil, S., Barkate, H., Prabhudesai, P., Sr, B.S., Agrawal, G., Singh, A.K., Jadhav, A.Y., Patil, S.R., Bhagat, S., Patil, S. and Barkate, H. (2023). Fluticasone Furoate/Vilanterol Use Trends and Characteristics in Patients With Obstructive Airway Disease: A Real-World Study of 10,374 Patients From India. Cureus, [online] 15(2). doi:https://doi.org/10.7759/cureus.34825.

Reference.medscape.com. (n.d.). Arnuity Ellipta (fluticasone furoate) dosing, indications, interactions, adverse effects, and more. [online] Available at: https://reference.medscape.com/drug/arnuity-ellipta-fluticasone-furoate-999960.

Tabassom, A. and Cho, J.J. (2020). Epistaxis (Nose Bleed). [online] PubMed. Available at: https://www.ncbi.nlm.nih.gov/books/NBK435997/.

Tanz, R.R. (2018). Sore Throat. Nelson Pediatric Symptom-Based Diagnosis, [online] pp.1-14.e2. doi:https://doi.org/10.1016/B978-0-323-39956-2.00001-7.

Williams, D.M. (2018). Clinical pharmacology of corticosteroids. Respiratory Care, 63(6), pp.655–670. doi:https://doi.org/10.4187/respcare.06314.

Wu, W., Walters, R.D., Nadeau, G.A., Botnick, W. and Broughton, N. (2013). An integrated analysis of the efficacy of fluticasone furoate nasal spray versus placebo on the nasal symptoms of perennial allergic rhinitis. Allergy and asthma proceedings, 34(3), pp.283–291. doi:https://doi.org/10.2500/aap.2013.34.3662.

Yasir, M., Sonthalia, S. and Goyal, A. (2023). Corticosteroid adverse effects. [online] Nih.gov. Available at: https://www.ncbi.nlm.nih.gov/books/NBK531462/.

Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless — and best of all, it's free for practitioners.

Latest Articles

View more on Medication Fact Sheets
Subscribe to the magazine for expert-written articles straight to your inbox
Join the thousands of savvy readers who get root cause medicine articles written by doctors in their inbox every week!
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.

Hey practitioners! 👋 Join Dr. Chris Magryta and Dr. Erik Lundquist for a comprehensive 6-week course on evaluating functional medicine labs from two perspectives: adult and pediatric. In this course, you’ll explore the convergence of lab results across different diseases and age groups, understanding how human lab values vary on a continuum influenced by age, genetics, and time. Register Here! Register Here.